本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BridgeBio Pharma, Inc.

75.15
+1.091.46%
盤後74.67-0.4800-0.64%19:39 EST
成交量:159.72萬
成交額:1.19億
市值:144.82億
市盈率:-17.96
高:75.24
開:73.83
低:72.65
收:74.07
52周最高:75.24
52周最低:25.34
股本:1.93億
流通股本:1.51億
量比:0.93
換手率:1.06%
股息:- -
股息率:- -
每股收益(TTM):-4.1844
每股收益(LYR):-2.8793
淨資產收益率:-1789.67%
總資產收益率:-43.47%
市淨率:-7.49
市盈率(LYR):-26.10

資料載入中...

2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/05

重要事件披露

Form 8-K - Current report
2025/07/02

重要事件披露

Form 8-K - Current report
2025/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/23

重要事件披露

Form 8-K - Current report
2025/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/29

重要事件披露

Form 8-K - Current report